会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Preservation and restoration of hemoglobin in blood substitutes
    • 血液代用品中血红蛋白的保存和恢复
    • US5051353A
    • 1991-09-24
    • US233303
    • 1988-08-09
    • Lewis P. StrattonMartha C. FarmerAlan S. Rudolph
    • Lewis P. StrattonMartha C. FarmerAlan S. Rudolph
    • A61K38/42
    • A61K38/42
    • A hemoglobin-containing blood substitute preparation is protected from oxtion to methemoglobin. The protected preparation comprises between 10 mM and 60 mM of a compound selected from the group consisting of glutathione (GSH), nicotinamide adenine dinucleotide (NADH), nicotine adenine dinucleotide phosphate (NADPH) and mixtures of these in the aqueous phase of a hemoglobin-containing fluid. Oxidized hemoglobin in a preparation can be restored by adding between 10 mM and 60 mM of a compound selected from the group consisting of glutathione (GSH), nicotinamide adenine dinucleotide (NADH), nicotine adenine dinucleotide phosphate (NADPH) and mixtures of these to a hemoglobin-containing fluid in which the hemoglobin has converted in whole or part to methemoglobin, and storing the fluid at storage temperatures for blood products above the freezing point of the fluid for a time sufficient to convert methemoglobin to hemoglobin.
    • 含血红蛋白的血液替代物制剂被保护免于氧化成高铁血红蛋白。 受保护的制剂包含10mM至60mM的选自谷胱甘肽(GSH),烟酰胺腺嘌呤二核苷酸(NADH),尼古丁腺嘌呤二核苷酸磷酸(NADPH)的化合物及其在血红蛋白 - 含有液体。 通过加入10mM至60mM的选自谷胱甘肽(GSH),烟酰胺腺嘌呤二核苷酸(NADH),尼古丁腺嘌呤二核苷酸磷酸(NADPH)和它们的混合物的化合物组合,可以恢复制剂中的氧化血红蛋白 其中血红蛋白全部或部分转化为高铁血红蛋白,并将流体存储在高于流体凝固点的血液制品的储存温度上足以将高铁血红蛋白转化成血红蛋白的时间。
    • 8. 发明授权
    • .sup.99m Tc labeled liposomes
    • 99MTC标签脂肪
    • US5143713A
    • 1992-09-01
    • US610204
    • 1990-11-05
    • William T. PhillipsRobert W. KlipperJames H. TimmonsAlan S. Rudolph
    • William T. PhillipsRobert W. KlipperJames H. TimmonsAlan S. Rudolph
    • A61K51/12
    • A61K51/1234A61K2123/00Y10T428/2984
    • The invention relates to the efficient preparation of radionuclide labeled liposomes and radionuclide-labeled liposome-encapsulated protein. In particular, a .sup.99m Tc carrier is used to label preformed liposomes or liposome-encapsulated hemoglobin. .sup.99m Tc-labeled liposomes and liposome-encapsulated .sup.99m Tc labeled hemoglobin are highly stable in vitro and in vivo and are suitable for a variety of clinical uses, including biodistribution imaging studies. The invention also relates to a method of labeling neutrophils using .sup.99m technetium-labeled liposomes or liposome-encapsulated hemoglobin. A kit method useful for the convenient preparation of .sup.99m Tc-labeled liposomes or liposome-encapsulated hemoglobin for clinical use is also disclosed.
    • 本发明涉及放射性核素标记的脂质体和放射性核素标记的脂质体包封的蛋白质的有效制备。 特别地,99mTc载体用于标记预先形成的脂质体或脂质体包封的血红蛋白。 99mTc标记的脂质体和脂质体包封的99mTc标记的血红蛋白在体外和体内都是高度稳定的,并且适用于各种临床用途,包括生物分布成像研究。 本发明还涉及使用99mtechnet标记的脂质体或脂质体包封的血红蛋白标记嗜中性粒细胞的方法。 还公开了用于方便地制备用于临床用途的99mTc标记的脂质体或脂质体包封的血红蛋白的试剂盒方法。